Reciprocally, HIF2α can increase PVT1 expression by occupying the HRE within the enhancer of PVT1 and form a positive feedback loop, thus the sustained HIF2α will mediate PVT1 oncogenic functions for ccRCC tumorigenesis. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.